CD300LF and infection: Using CRISPR-Cas9 technology, a gene that encodes a cell-surface protein that contained an immunoglobin domain and belonged to a lipid protein family was most significantly enriched in the surviving cells, Cd300lf. It was confirmed that this was the receptor from studies showing that knocking out Cd300lf in BV2 cells blocked infection by MNV.